A股異動 | 博威合金午後直線拉漲逾6% 公司產品已應用於TWS耳機核心部件
格隆匯12月6日丨博威合金(601137.SH)午後直線拉昇,現報10.66元,漲6.07%,暫成交1.3億元,最新總市值73億元。博威合金今日在互動平台表示,經過公司和客户多方確認,公司產品已經應用於TWS耳機核心部件之上,並已實現量產供應。此外還稱,type-C接口是公司高強高導材料的主要應用場景之一,目前的增速仍然是100%的增長速度,也是未來5G產品應用的主要方向。華泰證券此前表示,關注銅鋁季節性投資機會,受益於市場憂慮情緒舒緩、短期供需格局預期向好、美元短期下跌以及產業鏈低庫存。電子和軍工材料景氣確立,參考歷史估值相對底部把握投資機遇,建議關注博威合金等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.